Higher retinal re-attachment success in patients with complete PVD

Article

The presence of a complete posterior vitreous detachment (PVD) may be associated with an increased likelihood for primary anatomic success following retinal detachment surgery in phakic eyes.

The presence of a complete posterior vitreous detachment (PVD) may be associated with an increased likelihood for primary anatomic success following retinal detachment surgery in phakic eyes, according to a report published in the September issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

Flavio Rezende from McGill University, Montreal, Canada and colleagues from centres across Brazil and the USA ultrasonographically evaluated the preoperative status of the posterior vitreoretinal interface in 50 phakic eyes of 49 patients undergoing surgery for retinal detachment. Twenty-two eyes (44%) had a partial PVD and 28 eyes (56%) had complete PVD.

Surgeons performed pneumatic retinopexy in 18 eyes, scleral buckling in 15 eyes and pars plana vitrectomy in 17 eyes. It was discovered that 38 eyes (76%) achieved retinal re-attachment after just one surgical procedure, including 12 eyes with partial PVD and 26 eyes with complete PVD.

Among subjects undergoing pneumatic retinopexy, those with complete PVD demonstrated a significantly higher primary anatomic success rate compared with those with a partial PVD (p=0.02). By the 12-month follow-up, patients with partial PVD had undergone an average of 1.7 interventions, compared with just 1.1 in patients with complete PVD.

The report concluded that phakic eyes with complete PVD are more likely to achieve primary anatomic success following retinal detachment surgery than those with partial PVD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.